JP2022503733A5 - - Google Patents

Info

Publication number
JP2022503733A5
JP2022503733A5 JP2021515005A JP2021515005A JP2022503733A5 JP 2022503733 A5 JP2022503733 A5 JP 2022503733A5 JP 2021515005 A JP2021515005 A JP 2021515005A JP 2021515005 A JP2021515005 A JP 2021515005A JP 2022503733 A5 JP2022503733 A5 JP 2022503733A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
pharmaceutically acceptable
administered
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021515005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022503733A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056772 external-priority patent/WO2020081839A1/en
Publication of JP2022503733A publication Critical patent/JP2022503733A/ja
Publication of JP2022503733A5 publication Critical patent/JP2022503733A5/ja
Pending legal-status Critical Current

Links

JP2021515005A 2018-10-17 2019-10-17 口腔粘膜炎を治療するための方法および組成物 Pending JP2022503733A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746943P 2018-10-17 2018-10-17
US62/746,943 2018-10-17
PCT/US2019/056772 WO2020081839A1 (en) 2018-10-17 2019-10-17 Methods and compositions for treating oral mucositis

Publications (2)

Publication Number Publication Date
JP2022503733A JP2022503733A (ja) 2022-01-12
JP2022503733A5 true JP2022503733A5 (enExample) 2022-10-26

Family

ID=70281364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515005A Pending JP2022503733A (ja) 2018-10-17 2019-10-17 口腔粘膜炎を治療するための方法および組成物

Country Status (12)

Country Link
US (2) US11123357B2 (enExample)
EP (1) EP3866810A4 (enExample)
JP (1) JP2022503733A (enExample)
KR (1) KR20210075968A (enExample)
CN (1) CN112839662A (enExample)
AU (1) AU2019361999A1 (enExample)
BR (1) BR112021006954A2 (enExample)
CA (1) CA3116157A1 (enExample)
IL (1) IL282100A (enExample)
MX (1) MX2021004396A (enExample)
SG (1) SG11202103180QA (enExample)
WO (1) WO2020081839A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11795192B2 (en) * 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US12030908B2 (en) 2017-03-10 2024-07-09 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
WO2024129985A2 (en) * 2022-12-14 2024-06-20 Lakewood Amedex, Inc. Antiviral compounds, compositions, and uses thereof
WO2025179296A1 (en) * 2024-02-22 2025-08-28 Lakewood Amedex, Inc. Crystalline forms of nu-3 and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US5167950A (en) 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
EP0748203A1 (en) 1994-03-11 1996-12-18 The Procter & Gamble Company LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES
US6211349B1 (en) 1998-12-30 2001-04-03 Oligos Etc., Inc. Protonated/acidified nucleic acids and methods of use
US20020032164A1 (en) 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US7868162B2 (en) 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
US6211162B1 (en) 1998-12-30 2001-04-03 Oligos Etc. Inc. Pulmonary delivery of protonated/acidified nucleic acids
PT1152009E (pt) 1999-02-12 2005-03-31 Sankyo Co Novos analogos de nucleosidos e oligonucleotidos
US6946118B1 (en) * 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
EP1435970A4 (en) 2001-10-18 2005-05-04 Ilex Products Inc METHOD FOR TREATING THE SKIN WITH DIPHOSPHONATE DERIVATIVES
DE60325353D1 (de) * 2002-05-21 2009-01-29 Abbott Lab Behandlung von mukositis
CN1687100A (zh) * 2005-04-05 2005-10-26 奥林格斯技术有限公司 修饰性核苷酸及其用途
US8227431B2 (en) 2008-03-17 2012-07-24 Hetero Drugs Limited Nucleoside derivatives
US8884000B2 (en) 2010-02-17 2014-11-11 Albert Einstein College Of Medicine Of Yeshiva University Saporin-L1 inhibitors and uses thereof
WO2012017434A2 (en) * 2010-08-03 2012-02-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compounds for treating bacterial infections
SG11201407326XA (en) * 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of mucositis
WO2014124430A1 (en) 2013-02-11 2014-08-14 Emory University Nucleotide and nucleoside therapeutic compositions and uses related thereto
WO2015075406A1 (en) 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
EP3215126A1 (en) * 2014-10-30 2017-09-13 Biomet Manufacturing, LLC Methods of preventing surgical site infections
US10172786B2 (en) * 2014-12-16 2019-01-08 Axim Biotechnologies, Inc. Oral care composition comprising cannabinoids
WO2017165673A1 (en) * 2016-03-23 2017-09-28 University Of Utah Research Foundation Spinal traction device
KR102684529B1 (ko) * 2017-03-10 2024-07-12 레이크우드 아메덱스, 인크. 항미생물 화합물, 조성물, 및 그의 용도
KR20230031370A (ko) * 2017-06-12 2023-03-07 레이크우드 아메덱스, 인크. 비스포스포신 겔 제제 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2019189650A5 (enExample)
JP2016517431A5 (enExample)
JP3597333B2 (ja) 急性鼻炎を処置するための医薬製剤
JP2013513612A5 (enExample)
JP2009544665A5 (enExample)
JP2012520882A5 (enExample)
JP2016512246A5 (enExample)
JPWO2023054732A5 (enExample)
JP2020523322A5 (enExample)
JP6461002B2 (ja) 口腔局所用組成物
JP2020510085A5 (enExample)
JP2021073194A5 (enExample)
MX2024014315A (es) Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas
JP2023553253A5 (enExample)
RU2005133665A (ru) Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств
RU2012149868A (ru) Полисахарид семян для применения в лечении воспалительных заболеваний
RU2005105302A (ru) Композиция бицифадина
JP2011529936A5 (enExample)
JP2012526099A5 (enExample)
JP2022500445A5 (enExample)
JP2023520703A5 (enExample)
RU2008110933A (ru) Применение амброксола для лечения риновирусных инфекций
AU754329B2 (en) Fungicide composition comprising a benzoylphenylurea
CN103732224B (zh) 用于眼睫毛生长的组合物
CN103189041B (zh) 手指甲或脚趾甲生长促进用组合物